SCHEMBL14975604

SCHEMBL14975604

CC(=O)Nc1cc(Oc2cc(F)c(N(C(=O)c3c(OC(C)C)cc[nH]c3=O)c3ccc(F)cc3)cc2F)ccn1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 6/20 0.46
▸ MET P08581 12/20 0.43
▸ KDR P35968 6/20 0.43
▸ RIPK2 O43353 2/20 0.39
▸ RIPK1 Q13546 2/20 0.39
▸ RIPK3 Q9Y572 2/20 0.39
▸ CSF1R P07333 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ TYRO3 Q06418 1/20 0.38
▸ GCK P35557 1/20 0.37
▸ BRAF P15056 1/20 0.37
▸ NTRK1 P04629 1/20 0.36
▸ TEK Q02763 1/20 0.36
▸ NTRK3 Q16288 1/20 0.36
▸ NTRK2 Q16620 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14975335 0.92 AXL (0.47) AXLMETKDRRIPK2RIPK1
SCHEMBL14975552 0.90 MET (0.44) AXLMETKDRRIPK2RIPK1
SCHEMBL14975764 0.88 MET (0.43) AXLMETKDRCSF1RPDGFRB
SCHEMBL14975674 0.88 MET (0.38) AXLMETKDRRIPK2RIPK1
SCHEMBL14975863 0.87 MET (0.42) AXLMETKDRGCKBRAF
SCHEMBL14975389 0.85 MET (0.46) AXLMETKDRTYRO3GCK
SCHEMBL14975396 0.84 MET (0.41) AXLMETKDRCSF1RPDGFRB
SCHEMBL14975545 0.84 MET (0.47) AXLMETKDRRIPK2RIPK1
SCHEMBL14975035 0.83 MET (0.42) AXLMETKDRCSF1RGCK
SCHEMBL14975314 0.82 KDR (0.48) AXLMETKDRRIPK2RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782577-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES Deciphera Pharmaceuticals, LLC. (US) 2014-10-01 — — EP disclosed
WO-2013078295-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES DECIPHERA PHARMACEUTICALS, LLC (US) 2013-05-30 — — WO disclosed
Send feedback